Association of A1C and Fasting Plasma Glucose Levels With Diabetic Retinopathy Prevalence in the U.S. Population
Open accessThe DOI matches its Crossref record; 28 of the 29 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: To examine the association of A1C levels and fasting plasma glucose (FPG) with diabetic retinopathy in the U.S. population and to compare the ability of the two glycemic measures to discriminate between people with and without retinopathy. RESEARCH DESIGN AND METHODS: This study included 1,066 individuals aged ≥40 years from the 2005–2006 National Health and Nutrition Examination Survey. A1C, FPG, and 45° color digital retinal images were assessed. Retinopathy was defined as a level ≥14 on the Early Treatment Diabetic Retinopathy Study severity scale. We used joinpoint regression to identify linear inflections of prevalence of retinopathy in the association between A1C and FPG. RESULTS: The overall prevalence of retinopathy was 11%, which is appreciably lower than the prevalence in people with diagnosed diabetes (36%). There was a sharp increase in retinopathy prevalence in those with A1C ≥5.5% or FPG ≥5.8 mmol/l. After excluding 144 people using hypoglycemic medication, the change points for the greatest increase in retinopathy prevalence were A1C 5.5% and FPG 7.0 mmol/l. The coefficients of variation were 15.6 for A1C and 28.8 for FPG. Based on the areas under the receiver operating characteristic curves, A1C was a stronger discriminator of retinopathy (0.71 [95% CI 0.66–0.76]) than FPG (0.65 [0.60 – 0.70], P for difference = 0.009). CONCLUSIONS: The steepest increase in retinopathy prevalence occurs among individuals with A1C ≥5.5% and FPG ≥5.8 mmol/l. A1C discriminates prevalence of retinopathy better than FPG.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus* (2002) · Diabetes Care · doi:10.2337/diacare.25.2007.s5 · Cited by 10,338
Centers for Disease Control and Prevention
(2007) · Encyclopedia of Measurement and Statistics · doi:10.4135/9781412952644.n74 · Cited by 6,444
Permutation tests for joinpoint regression with applications to cancer rates
Kim, H.-J., Fay, M. P., Feuer, E. J., & Midthune, D. N. (2000) · Statistics in Medicine · doi:10.1002/(sici)1097-0258(20000215)19:3<335::aid-sim336>3.0.co;2-z · Cited by 6,318
Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (2003) · Diabetes Care · doi:10.2337/diacare.26.2007.s5 · Cited by 2,689
Sacks, D. B., Arnold, M., Bakris, G. L., Bruns, D. E., Horvath, A. R., Kirkman, M. S., Lernmark, A., Metzger, B. E., & Nathan, D. M. (2011) · Clinical Chemistry · doi:10.1373/clinchem.2010.161596 · Cited by 1,360
Sacks, D. B., Bruns, D. E., Goldstein, D. E., Maclaren, N. K., McDonald, J. M., & Parrott, M. (2002) · Clinical Chemistry · doi:10.1093/clinchem/48.3.436 · Cited by 1,130
Diabetic Retinopathy in a Multi-ethnic Cohort in the United States
Wong, T. Y., Klein, R., Islam, F. M. A., Cotch, M. F., Folsom, A. R., Klein, B. E. K., Sharrett, A. R., & Shea, S. (2006) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2005.08.063 · Cited by 684 · cited 1×
“Moreover, retinopathy in the absence of diabetes (FPG 7 mmol/l) was more frequent among individuals of minority racial groups than whites (16), suggesting a higher likelihood of retinopathy not due to hyperglycemia among minority populations.”
BackgroundSelf-citationHerman, W. H., Ma, Y., Uwaifo, G., Haffner, S., Kahn, S. E., Horton, E. S., Lachin, J. M., Montez, M. G., Brenneman, T., Barrett-Connor, E., et al. (2007) · Diabetes Care · doi:10.2337/dc06-2003 · Cited by 574
McCane, D. R., Hanson, R. L., Charles, M. A., Jacobsson, L. T. H., Pettitt, D. D., Bennett, P. H., & Knowler, W. C. (1994) · BMJ · doi:10.1136/bmj.308.6940.1323 · Cited by 484 · cited 3×
“Second, we applied the cut points used in an analysis of the Pima Indians (2).”
BackgroundMethodResultInfluentialAssessing Glycemia in Diabetes Using Self-monitoring Blood Glucose and Hemoglobin A 1c
Saudek, C. D., Derr, R. L., & Kalyani, R. R. (2006) · JAMA · doi:10.1001/jama.295.14.1688 · Cited by 373 · cited 1×
“While hemoglobinopathies and race/ethnicity may reduce the validity of A1C as a diagnostic tool (17,18), A1C level has less variability than FPG (7–9).”
BackgroundDiabetes Prevention Program Research Group (2007) · Diabetic Medicine · doi:10.1111/j.1464-5491.2007.02043.x · Cited by 363
Engelgau, M. M., Thompson, T. J., Herman, W. H., Boyle, J. P., Aubert, R. E., Kenny, S. J., Badran, A., Sous, E. S., & Ali, M. A. (1997) · Diabetes Care · doi:10.2337/diacare.20.5.785 · Cited by 325
Wong, T. Y., Liew, G., Tapp, R. J., Schmidt, M. I., Wang, J. J., Mitchell, P., Klein, R., Klein, B. E., Zimmet, P., & Shaw, J. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60343-8 · Cited by 243 · cited 6×
“Similar findings have been reported by others (5).”
BackgroundResultInfluentialSelf-citationDavidson, M. B., Schriger, D. L., Peters, A. L., & Lorber, B. (1999) · JAMA · doi:10.1001/jama.281.13.1203 · Cited by 189
Utility of A1C for Diabetes Screening in the 1999–2004 NHANES Population
Buell, C., Kermah, D., & Davidson, M. B. (2007) · Diabetes Care · doi:10.2337/dc07-0585 · Cited by 161
Leure‐Dupree, A. E. (1981) · PubMed · Cited by 156
Cohen, R. M., Snieder, H., Lindsell, C. J., Beyan, H., Hawa, M. I., Blinko, S., Edwards, R., Spector, T. D., & Leslie, R. D. G. (2006) · Diabetes Care · doi:10.2337/dc06-0286 · Cited by 144
Longitudinal Association of Glucose Metabolism With Retinopathy
Tapp, R. J., Tikellis, G., Wong, T. Y., Harper, C. A., Zimmet, P. Z., Shaw, J. E., & on behalf of the Australian Diabetes Obesity and Lifestyle Study Group (2008) · Diabetes Care · doi:10.2337/dc07-1707 · Cited by 114
Diagnosing diabetes mellitus - do we need new criteria?
McCance, D. R., Hanson, R. L., Pettitt, D. J., Bennett, P. H., Hadden, D. R., & Knowler, W. C. (1997) · Diabetologia · doi:10.1007/s001250050671 · Cited by 106 · cited 1×
“The presence of diabetic retinopathy is arguably the best criterion from which to compare glycemic measures because it is a specific and early clinical complication usually related to diabetes, and it represents a specific and relevant clinical end point for judging an alternative test (1).”
BackgroundKlein, R., Klein, R., Moss, S. E., & Wong, T. Y. (2006) · Europe PMC (PubMed Central) · Cited by 95
Self-citationDay-to-day variability of fasting plasma glucose in newly diagnosed type 2 diabetic subjects.
Ollerton, R. L., Playle, R., Ahmed, K., Dunstan, F. D., Luzio, S. D., & Owens, D. R. (1999) · Diabetes Care · doi:10.2337/diacare.22.3.394 · Cited by 90
Miyazaki, M., Kubo, M., Kiyohara, Y., Okubo, K., Nakamura, H., Fujisawa, K., Hata, Y., Tokunaga, S., Iida, M., Nose, Y., et al. (2004) · Diabetologia · doi:10.1007/s00125-004-1466-8 · Cited by 68 · cited 1×
“5%) (13) but lower than that observed in some previous studies, including the Pima Indian study (6.”
ResultComparison of Percent Total GHb With Percent HbA1c in People With and Without Known Diabetes
Nuttall, F. Q. (1998) · Diabetes Care · doi:10.2337/diacare.21.9.1475 · Cited by 63 · cited 2×
“Nevertheless, Nuttall (24,25) argued that affinity chromatography has significant advantages over the ion-exchange HPLC, especially among people with diabetes, including less interference by hemoglobinopathies, more reliability, and no need for validation by the complicated mass spectrometry method.”
BackgroundFrequency of HbA1c discordance in estimating blood glucose control
Cohen, R. M., & Smith, E. P. (2008) · Current Opinion in Clinical Nutrition and Metabolic Care · doi:10.1097/mco.0b013e32830467bd · Cited by 58 · cited 1×
“Glycation rate is also influenced by factors other than the level of plasma glucose (20).”
BackgroundPetersen, P. H., Jørgensen, L. G. M., Brandslund, I., De Fine Olivarius, N., & Stahl, M. (2005) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.1080/00365510500236135 · Cited by 51
Analytic Bias Among Certified Methods for the Measurement of Hemoglobin A1c: A Cause for Concern?
Holmes, E. W., Erşahin, Ç., Augustine, G. J., Charnogursky, G. A., Gryzbac, M., Murrell, J. V., McKenna, K. M., Nabhan, F., & Kahn, S. E. (2008) · American Journal of Clinical Pathology · doi:10.1309/u3gpptcbp1vll8aw · Cited by 49 · cited 2×
“Third, variability among different assay methods of A1C is a potential source of inaccuracy whenever A1C results are interpreted relative to universal, fixed, clinical decision thresholds (15).”
BackgroundTotal Glycohemoglobin or Hemoglobin A1c?
Nuttall, F. Q. (2007) · Endocrine Practice · doi:10.4158/ep.13.3.317 · Cited by 2
Cited by
Diabetes mellitus: The epidemic of the century
Kharroubi, A. T. (2015) · World Journal of Diabetes · doi:10.4239/wjd.v6.i6.850 · Cited by 1,229
Prevalence of Diabetic Retinopathy in the United States, 2005-2008
Zhang, X., Saaddine, J. B., Chou, C.-F., Cotch, M. F., Cheng, Y. J., Geiss, L. S., Gregg, E. W., Albright, A. L., Klein, B. E. K., & Klein, R. (2010) · JAMA · doi:10.1001/jama.2010.1111 · Cited by 1,196
Self-citationPioglitazone for Diabetes Prevention in Impaired Glucose Tolerance
DeFronzo, R. A., Tripathy, D., Schwenke, D. C., Banerji, M., Bray, G. A., Buchanan, T. A., Clement, S. C., Henry, R. R., Hodis, H. N., Kitabchi, A. E., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1010949 · Cited by 766
Perreault, L., Pan, Q., Mather, K. J., Watson, K. E., Hamman, R. F., & Kahn, S. E. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60525-x · Cited by 532
Fox, C. S., Golden, S. H., Anderson, C., Bray, G. A., Burke, L. E., de Boer, I. H., Deedwania, P., Eckel, R. H., Ershow, A. G., Fradkin, J., et al. (2015) · Diabetes Care · doi:10.2337/dci15-0012 · Cited by 492
Metadata
- Authors
- Cheng, Y. J., Gregg, E. W., Geiss, L. S., Imperatore, G., Williams, D. E., Zhang, X., Albright, A. L., Cowie, C. C., Klein, R., & Saaddine, J. B.
- Affiliations
- Centers for Disease Control and Prevention (US)
- National Institute of Diabetes and Digestive and Kidney Diseases (US)
- University of Wisconsin–Madison (US)
- Corresponding author
- Cheng, Yiling J.
- ORCID
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2009-11-01
- Volume
- 32
- Issue
- 11
- Pages
- 2027-2032
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC2768189
- OpenAlex
- W2163807150
- Cited by
- 157
- References
- 29
- Citations by year
- 2026: 1 · 2025: 6 · 2024: 7 · 2023: 4 · 2022: 5 · 2021: 5 · 2020: 8 · 2019: 5 · 2018: 7 · 2017: 10 · 2016: 12 · 2015: 20 · 2014: 19 · 2013: 10 · 2012: 15
- FWCI
- 12.89
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes Care (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Spiral (Imperial College London) (submittedVersion, cc-by-nc-nd)
- Topics
- Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Retinal Imaging and Analysis
- Keywords
- diabetic retinopathy, HbA1c, fasting blood glucose, glycemic control, retinopathy prevalence, retinopathy screening, diagnostic discrimination, color fundus photography, undiagnosed diabetes, NHANES
- MeSH terms
- Blood Glucose, Diabetic Angiopathies, Diabetic Retinopathy, Ethnicity, Fasting, Female, Glycated Hemoglobin, Humans, Hypertension, Male, Middle Aged, Nutrition Surveys, Sensitivity and Specificity, United States, Prevalence, Patient Selection, Racial Groups
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.

